Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Podestà, M.
Right arrow Articles by Bacigalupo, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Podestà, M.
Right arrow Articles by Bacigalupo, A.
Related Collections
Right arrow Hematopoiesis
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

The Assessment of the Hematopoietic Reservoir After Immunosuppressive Therapy or Bone Marrow Transplantation in Severe Aplastic Anemia

Marina Podestà, Giovanna Piaggio, Francesco Frassoni, Anna Pitto, Panagiotis Zikos, Mario Sessarego, Monica Abate, Maria Teresa Van Lint, Giovanni Berisso, and Andrea Bacigalupo

From Divisione Ematologia 2, Ospedale S. Martino, Genova, Italy; and Laboratorio Citogenetica, DIMI, Università degli Studi, Genova, Italy.

We investigated the hematopoietic reservoir in 43 severe aplastic anemia (SAA) patients following immunosuppression (IS) (n = 15) or bone marrow transplantation (BMT) (n = 28), at a median interval of 5 years (range, 2-20) from treatment. All patients had normal blood counts, good marrow cellularity, and normal numbers of colony forming unit-granulocyte macrophages (CFU-GM). Burst forming unit-erythroid (BFU-E) and colony forming unit-granulocyte erythroid megakaryocyte macrophages (CFU-GEMM) numbers were reduced when compared with normal controls. However, the most pronounced defect was observed at the level of long-term culture-initiating cells (LTC-IC), which significantly differed from controls (P < .00001) both for IS and BMT patients. Their number did not improve with time and was not affected by transplant or treatment-related variables. When IS patients were compared with BMT we found comparable numbers of CFU-GEMM (P = .8) and LTC-IC (P = .9), but lower numbers of BFU-E and CFU-GM (P = .05 and P = .004, respectively), suggestive of a persistent suppressive mechanism. These data indicate that LTC-IC numbers are severely reduced in BMT and IS patients, contradicting the common belief that the former are fully reconstituted as compared with the latter. In addition, the number of mature cells and committed progenitors does not seem to reflect the real size of the hematopoietic reservoir and few stem cells may be sufficient to guarantee normal hematopoiesis long term.

Blood, Vol. 91 No. 6 (March 15), 1998: pp. 1959-1965
© 1998 by The American Society of Hematology.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
haematolHome page
N. Sessarego, A. Parodi, M. Podesta, F. Benvenuto, M. Mogni, V. Raviolo, M. Lituania, A. Kunkl, G. Ferlazzo, F. D. Bricarelli, et al.
Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application
Haematologica, March 1, 2008; 93(3): 339 - 346.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
M. W. Drummond, S. Balabanov, T. L. Holyoake, and T. H. Brummendorf
Concise Review: Telomere Biology in Normal and Leukemic Hematopoietic Stem Cells
Stem Cells, August 1, 2007; 25(8): 1853 - 1861.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
A. Bacigalupo
Aplastic Anemia: Pathogenesis and Treatment
Hematology, January 1, 2007; 2007(1): 23 - 28.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. Zeng, A. Miyazato, G. Chen, S. Kajigaya, N. S. Young, and J. P. Maciejewski
Interferon-{gamma}-induced gene expression in CD34 cells: identification of pathologic cytokine-specific signature profiles
Blood, January 1, 2006; 107(1): 167 - 175.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Frassoni, M. Podesta, R. Maccario, G. Giorgiani, G. Rossi, M. Zecca, A. Bacigalupo, G. Piaggio, and F. Locatelli
Cord blood transplantation provides better reconstitution of hematopoietic reservoir compared with bone marrow transplantation
Blood, August 1, 2003; 102(3): 1138 - 1141.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Engelhardt, J. Finke, N. Rufer, T. H. Brummendorf, B. Chapuis, C. Helg, P. M. Lansdorp, and E. Roosnek
Does telomere shortening count?
Blood, August 1, 2001; 98(3): 888 - 890.
[Full Text] [PDF]


Home page
BloodHome page
T. H. Brummendorf, J. P. Maciejewski, J. Mak, N. S. Young, and P. M. Lansdorp
Telomere length in leukocyte subpopulations of patients with aplastic anemia
Blood, February 15, 2001; 97(4): 895 - 900.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
C. V. Cox, S. B. Killick, S. Patel, M. O. Elebute, J. C.W. Marsh, E. C. Gordon-Smith, and F. M. Gibson
In Vitro Proliferation and Differentiation of Megakaryocytic Progenitors in Patients with Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, and the Myelodysplastic Syndromes
Stem Cells, November 1, 2000; 18(6): 428 - 434.
[Abstract] [Full Text]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 1998 by American Society of Hematology         Online ISSN: 1528-0020